Adarx Pharmaceuticals, Inc.
Clinical trials sponsored by Adarx Pharmaceuticals, Inc., explained in plain language.
-
New hope for swelling disorder: experimental drug enters human trials
Disease control OngoingThis study tests a new drug called ADX-324 for hereditary angioedema, a genetic condition that causes sudden, painful swelling attacks. The trial has two parts: first, healthy volunteers receive a single dose to check safety; second, patients with the condition receive multiple d…
Phase: PHASE1, PHASE2 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:15 UTC
-
New hypertension drug ADX-850 enters first human safety trial
Disease control OngoingThis early-stage study tests a new medicine called ADX-850 in 28 adults with mild to moderate high blood pressure. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure changes in blood pressure over time.
Phase: PHASE1 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:14 UTC